Anal Bioanal Chem
Analytical and Bioanalytical Chemistry
1618-2642
1618-2650
Springer-Verlag
Berlin/Heidelberg


1592253
16850295
541
10.1007/s00216-006-0541-z
Review


Optical molecular imaging for systems biology: from molecule to organism

Du
Wei



Wang
Ying



Luo
Qingming



Liu
Bi-Feng

+86-27-87792203
+86-27-87792203
bfliu@mail.hust.edu.cn



The Key Laboratory of Biomedical Photonics of MOE—Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Systems Biology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074 People’s Republic of China 

19
7
2006

10
2006

386
3
444
457
31
1
2006

1
5
2006

9
5
2006


© Springer-Verlag 2006

The development of highly efficient analytical methods capable of probing biological systems at system level is an important task that is required in order to meet the requirements of the emerging field of systems biology. Optical molecular imaging (OMI) is a very powerful tool for studying the temporal and spatial dynamics of specific biomolecules and their interactions in real time in vivo. In this article, recent advances in OMI are reviewed extensively, such as the development of molecular probes that make imaging brighter, more stable and more informative (e.g., FPs and semiconductor nanocrystals, also referred to as quantum dots), the development of imaging approaches that provide higher resolution and greater tissue penetration, and applications for measuring biological events from molecule to organism level, including gene expression, protein and subcellular compartment localization, protein activation and interaction, and low-mass molecule dynamics. These advances are of great significance in the field of biological science and could also be applied to disease diagnosis and pharmaceutical screening. Further developments in OMI for systems biology are also proposed.

Keywords
Optical molecular imaging
Fluorescent protein
Quantum dots
Systems biology
Review

issue-copyright-statement
© Springer-Verlag 2006




Introduction
1
5
6
3
].
7
8
omic
 investigations, which relate to the basic structures of systems, it is important to have methods capable of monitoring their localizations, connections, and in particular their dynamics over time under various physiological or pathological conditions.
1
9
11
Fig. 1
left
right
) digitally and quantitatively. It can handle a wide range of intensities (about 12 orders of magnitude), times (femtoseconds to years) and spatial dimensions (nanometers to centimeters), and it gives high spatial and temporal resolution of the targeted cellular structures—better than any other method





Advances in fluorescent probes
Aequorea
 fluorescent protein (AFP)-derived mutants
Labeling of biomolecules with fluorescent probes or other dyes has facilitated in vitro or in vivo studies of biomolecular structures and dynamics, as well as their interactions, which is critical if we are to understand the biomolecular mechanisms of cellular function. However, traditional methods of chemical labeling based on fluorescent dyes are often inadequate for biomolecular labeling, repurification and reintroduction into cells by invasive methods like microinjection. These limitations have spawned efforts to noninvasively and site-specifically label protein in living cells or tissues by using green fluorescent protein (GFP) and its variants. The fluorescent protein presents a relatively small size and a compact, single-domain structure, which allow it to fuse to other targeted proteins with little or no interference in native protein.
Aequorea victoria
2
12
13
14
15
16
17
18
Fig. 2a–c
a
b
c
 Interchanging the amino and carboxyl portions of GFP and rejoining them with a short spacer generates cpGFP





Other kinds of fluorescent protein
Discosoma genus
19
20
21
2
22
23
24
Fungia concinn
25
26
Trachyphyllia geoffroyi
, can convert from green to red fluorescence and brightens 2,000-fold under UV illumination.

New rearrangement variants of fluorescent protein
2
K
a
27
28
].

Nongenetic fluorescent probes
C. elegans
Drosophila
 or surface structures in small animals. To solve these problems, applying QDs (quantum dots) to OMI of the whole-body could allow us to visualize biological events in deeper tissues with better image quality.
29
30
31
32
33
34
3
35
36
Fig. 3
Method of conjugating QDs to target proteins. The pG-zb acts as a molecular adaptor, connecting the QDs with the target protein through interactions of its protein G portion with a specific antibody as well as interactions of its positively charged tail with QDs capped with a negatively charged dihydrolipoic acid surface






OMI techniques
General imaging microscopy
4
37
38
37
38
Fig. 4a–f
a
b
c
d
51
e
red
yellow
57
f
black
59
] with permission




39
4
40
].

Second-harmonic imaging microscopy (SHIM)
41
]. Biological macromolecules often assemble into large, ordered noncentrosymmetric structures and have highly polarizability. Therefore, high-resolution SHIM imaging can visualize living cells or tissues. This method provides several benefits: the targeted molecules are not excited, photobleaching does not occur, and it can detect information related to pathology. In addition, a combination of SHIM and MPLSM could make a powerful optical imaging technique.

Optical coherence tomography (OCT)
42
43
44
]. Several features of OCT imaging make it well-suited to imaging-based diagnostics and surgical guidance, such as its high resolution, its ability to quantitatively assess, and its ability to image some tissue functions.


Fluorescent molecular imaging approaches
Fluorescence resonance energy transfer (FRET)
4
45
46
47
46
48
47
49
].

Fluorescence recovery after photobleaching (FRAP)
4
50
51
52
] have been studied using this approach.

Fluorescence lifetime imaging microscopy (FLIM)
53
54
4
55
56
57
]. The main drawbacks of FLIM are that it has relatively low sensitivity and requires expensive instrumentation.

Fluorescence correlation spectroscopy (FCS)
4
58
59
60
].


Applications of OMI
OMI for biomolecules
61
62
63
64
65
66
].
67
68
] using this method.
46
69
2+
70
].

Using OMI to monitor physiological processes in living cells
Monitoring gene expression and RNA localization
71
72
73
74
]. The principle behind this is that the fluorescence of FP, revealing targeted gene expression in different tissues, is magnified through a transcript factor, which allows weak signals to be seen.
75
76
]. Compared with FISH in vivo, the disadvantage of this method is the introduction of a protein complex of considerable size.

Monitoring protein and subcellular organelle dynamics
77
78
79
].
80
Arabidopsis
81
82
].

Monitoring general protein–protein interactions
5
83
84
85
46
86
6
87
88
Fig. 5a–d
a
b
c
d
 An intramolecular probe consists of CFP, YFP and a protein/domain, which permits conformational change by binding to another biomolecule, leading to a change in FRET



Fig. 6a–d
a
b
c
d
−
+






Monitoring protease and kinase activity
89
5
90
92
93
].
5
94
95
96
].

Monitoring changes in calcium
97
2+
5
28
98
99
2+
2+
2+
100
].
6
14
27
6
101
] have both been used as calcium indicators because a conformational change occurs in the fusion cpFPs upon calcium binding.

Monitoring changes in cyclic nucleotides
102
103
5
104
].
105
106
105
], and it exhibited decreased FRET fluorescence upon the binding of cGMP.

Monitoring changes in transmembrane voltage
107
+
+
+
108
109
] developed a new voltage-sensitive indicator based on FRET, in which changes in membrane voltage can lead to changes in FRET.

Monitoring changes in pH in living cells
12
6
Renilla reniformis
110
111
112
].

Monitoring signal transduction from cell to cell
113
114
115
].


Using OMI to investigate tissue structure and function
116
C. elegans
117
118
119
120
].
121
122
123
124
125
126
127
128
].

OMI of organisms
Employing fluorescent protein
129
]. Over the past few decades, FPs have been used to generate various fluorescent probes that have been used to image physiological and biochemical events in the monolayer cells. Extracting information from whole-body imaging is more relevant to real physiological conditions, but up to now, only a few fluorescent indicators have been used in complex organisms to visualize physiological activity in vivo.
C. elegans
130
C. elegans
2+
7
131
132
133
C. elegans
2+
Drosophila
134
7
135
7
136
137
138
139
140
Fig. 7a–k
2+
a
b
red color
C. elegans
130
c
f
2+
Drosophila
135
g
h
i
136
j
k
33
] with permission





Employing QDs
141
33
7
142
1
Table 1
OMI in systems biology

Techniques
Physical processes
Resolution
Sensitivity
Penetration
Observation methods
Probes
Indicator localization
References


WFM LSCM MPLSM
RNA transcription and expression
High
High
High
DFI, FRET
FPs
In vitro, cells, tissues, organism
63
64
71
76
]

Protein localization and dynamics



DFI
FPs
In vitro, cells, tissues, organism
51
52
65
77
79
]

Subcellular organelle dynamics



DFI, FRAP
FPs
Cells
80
82
]

Protein interaction



FRET, FLIM, FCS
FPs, cpFPs
Cells, mouse
46
47
49
57
59
60
83
88
140
]

Protease and kinase activity



FRET
FPs

89
96
]

Calcium



DFI, FRET
FPs, cpFPs
C. elegans
Drosophila

14
27
28
97
101
130
138
]

cAMP, cGMP



FRET
FPs
Cells
102
106
]

Electrical activity



DFI, FRET
FPs
Cells
107
109
]

pH



DFI, FRET
FPs
Cells, mouse
110
112
139
]

Tumor



DFI
QDs
Mouse
33
141
142
]

SHIM
Biomacromolecules
Low
High
Low
NI
–
C. elegans
, brain tissue
116
118
]

Membrane potential



NI
Dyes
Cells, brain tissue
119
120
]

OCT
Morphology of tissue
High
Low
High
EI
–
Human
122
123
]

Activity and disease of organ



EI
–
Human
124
125
]

RS
Composition of structure
Low
High
Low
NI
–
Brain tissues, bronchial tissue
126
127
]

FT-IR
Kinetics of reaction intermediates
Low
High
Low
NI
–
Yeast extract, fish liver
67
68
]



DFI
NI
EI
, light-echo imaging






Future development
8
])—in terms of sensitivity, selectivity or specificity, linear range of quantitation, throughput, robustness, flexibility and cost—that are definitely required in genomics, transcriptomics, proteomics, and metabolomic profiling and dynamics, although it it clear that OMI is a promising method for these types of bioanalysis.
143
144
145
]. Finally, the application of OMI to the life sciences is important; it is the reason behind the development of OMI. In particular, the application of OMI to systematic measurements of biological systems will be of great interest, which is also the aim of systems biology.


Acknowledgements
The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (Nos. 20405006, 30570468), the National High Technology Research and Development Program of China (863 Program: 2003AA231011), the Program for New Century Excellent Talents in University (NCET), and the Program for Distinguished Young Scientists of the Hubei Province (2004ABB004).

References
1.
Kitano H (ed) (2001) Foundations of systems biology. MIT Press, Cambridge, MA

2.
Liu
ET


Cell
2005
121
505
506

15907463


3.
Palsson
B


Nat Biotechnol
2000
18
1147
1150

11062431


4.
Hood
L

Perlmutter
RM


Nat Biotechnol
2004
22
1215
1217

15470453


5.
Kitano
H


Science
2002
295
1662
1664

11872829


6.
Weiner
N


Cybernetics or control and communication in the animal and the machine
1948
Cambridge, MA
MIT Press

Weiner N (1948) Cybernetics or control and communication in the animal and the machine. MIT Press, Cambridge, MA 

7.
Corttingham
K


Anal Chem
2005
77
197A

Corttingham K (2005) Anal Chem 77:197A 

8.
Liu
BF

Xu
B

Zhang
G

Du
W

Luo
Q


J Chromatogr A
2006
1106
19
29

16236294


9.
Stephens
DJ

Allan
VJ


Science
2003
300
82
86

12677057


10.
Farkas
DL


Nat Biotechnol
2003
21
1269
1271

14595349


11.
Farkas
D


Nat Biotechnol
2003
21
1269
1271

14595349


12.
Tsien
RY


Annu Rev Biochem
1998
67
509
544

9759496


13.
Ormo
M

Cubitt
AB

Kallio
K

Gross
LA

Tsien
RY

Remington
SJ


Science
1996
273
1392
1395

8703075


14.
Griesbeck
O

Baird
GS

Campbell
RE

Zacharias
DA

Tsien
RY


J Biol Chem
2001
276
29188
29194

11387331


15.
Nagai
T

Ibata
K

Park
ES

Kubota
M

Mikoshiba
K

Miyawaki
A


Nat Biotechnol
2002
20
87
90

11753368


16.
Rizzo
MA

Springer
GH

Granada
B

Piston
DW


Nat Biotechnol
2004
22
445
449

14990965


17.
Sawano
A

Miyawaki
A


Nucleic Acids Res
2000
28
e78

10931937


18.
Patterson
GH

Lippincott-Schwartz
J


Science
2002
297
1873
1877

12228718


19.
Matz
MV

Fradkov
AF

Labas
YA

Savitsky
AP

Zaraisky
AG

Markelov
ML

Lukyanov
SA


Nat Biotechnol
1999
17
969
973

10504696


20.
Terskikh
A

Fradkov
A

Ermakova
G

Zaraisky
A

Tan
P

Kajava
AV

Zhao
X

Lukyanov
S

Matz
M

Kim
S

Weissman
I

Siebert
P


Science
2000
290
1585
1588

11090358


21.
Campbell
RE

Tour
O

Palmer
AE

Steinbach
PA

Baird
GS

Zacharias
DA

Tsien
RY


Proc Natl Acad Sci USA
2002
99
7877
7882

12060735


22.
Terskikh
AV

Fradkov
AF

Zaraisky
AG

Kajava
AV

Angres
B


J Biol Chem
2002
277
7633
7636

11773062


23.
Bevis
BJ

Glick
BS


Nat Biotechnol
2002
20
83
87

11753367


24.
Shaner
NC

Campbell
RE

Steinbach
PA

Giepmans
BN

Palmer
AE

Tsien
RY


Nat Biotechnol
2004
22
1567
1572

15558047


25.
Karasawa
S

Araki
T

Nagai
T

Mizuno
H

Miyawaki
A


Biochem J
2004
381
307
312

15065984


26.
Ando
R

Hama
H

Yamamoto-Hino
M

Mizuno
H

Miyawaki
A


Proc Natl Acad Sci USA
2002
99
12651
12656

12271129


27.
Baird
GS

Zacharias
DA

Tsien
RY


Proc Natl Acad Sci USA
1999
96
11241
11246

10500161


28.
Nagai
T

Yamada
S

Tominaga
T

Ichikawa
M

Miyawaki
A


Proc Natl Acad Sci USA
2004
101
10554
10559

15247428


29.
Murray
CB

Kagan
CR

Bawendi
MG


Annu Rev Mater Sci
2000
30
545
610

Murray CB, Kagan CR, Bawendi MG (2000) Annu Rev Mater Sci 30:545–610 

30.
Green
M

O’Brien
P


J Chem Soc Chem Commun
1999
22
2235
2241

Green M, O’Brien P (1999) J Chem Soc Chem Commun 22:2235–2241 

31.
Leatherdale
CA

Woo
WK

Mikulec
FV

Bawendi
MG


J Phys Chem B
2002
106
7619
7622

Leatherdale CA, Woo WK, Mikulec FV, Bawendi MG (2002) J Phys Chem B 106:7619–7622 

32.
Gao
XH

Nie
SM


Trends Biotechnol
2003
21
371
373

12948664


33.
Jakobs
S

Subramaniam
V

Schonle
A

Jovin
TM

Hell
SW


FEBS Lett
2000
479
131
135

10981721


34.
Goldman
ER

Anderson
GP

Tran
PT

Mattoussi
H

Charles
PT

Mauro
JM


Anal Chem
2002
74
841
847

11866065


35.
Wang
DS

He
JB

Rosenzweig
N


Nano Lett
2004
4
409
413

Wang DS, He JB, Rosenzweig N (2004) Nano Lett 4:409–413 

36.
So
MK

Xu
C

Loening
AM

Gambhir
SS

Rao
J


Nat Biotechnol
2006
24
339
343

16501578


37.
Gerlich D, Ellenberg J (2003) Nat Cell Biol Suppl S14–S19

38.
Swedlow
JR

Platani
M


Cell Struct Funct
2002
27
335
341

12502887


39.
Denk
W

Strickler
JH

Webb
WW


Science
1990
248
73
76

2321027


40.
Lansford
R

Bearman
G

Fraser
SE


J Biomed Opt
2001
6
311
318

11516321


41.
Campagnola
PJ

Loew
LM


Nat Biotechnol
2003
21
1356
1360

14595363


42.
Fujimoto
JG


Nat Biotechnol
2003
21
1361
1367

14595364


43.
Drexler
W

Morgner
U

Kartner
FX

Pitris
C

Boppart
SA

Li
XD

Ippen
EP

Fujimoto
JG


Opt Lett
1999
24
1221
1223

18073990


44.
Schmitt
JM

Knüttel
A

Yadlowsky
M

Eckhaus
MA


Phys Med Biol
1994
39
1705
1720

15551540


45.
Sekar
RB

Periasamy
A


J Cell Biol
2003
160
629
633

12615908


46.
Zhang
J

Campbell
RE

Ting
AY

Tsien
RY


Nat Rev Mol Cell Biol
2002
3
906
918

12461557


47.
Miyawakib
A


Dev Cell
2003
4
295
305

12636912


48.
Berney
C

Danuser
G


Biophys J
2003
84
3992
4010

12770904


49.
Herman
B

Krishnan
RV

Centonze
VE


Methods Mol Biol
2004
261
351
370

15064469


50.
Phair
RD

Misteli
T


Nat Rev Mol Cell Biol
2001
2
898
907

11733769


51.
Schaaf
MJ

Cidlowski
JA


Mol Cell Biol
2003
23
1922
1934

12612067


52.
Shtrahman
M

Yeung
C

Nauen
DW

Bi
GQ

Wu
XL


Biophys J
2005
89
3615
3627

16113110


53.
Bastiaens
PI

Squire
A


Trends Cell Biol
1999
9
48
52

10087617


54.
Dong
CY

French
T

So
PT

Buehler
C

Berland
KM

Gratton
E


Methods Cell Biol
2003
72
431
464

14719344


55.
Wouters
FS

Verveer
PJ

Bastiaens
PI


Trends Cell Biol
2001
11
203
211

11316609


56.
Subramaniam
V

Hanley
QS

Clayton
AH

Jovin
TM


Methods Enzymol
2003
360
178
201

12622150


57.
Tertoolen
LG

Blanchetot
C

Jiang
G

Overvoorde
J

Gadella
TW

Hunter
T

Hertog
J


BMC Cell Biol
2001
2
8

11401727


58.
Berland
KM


Meth Mol Biol
2004
261
383
398

Berland KM (2004) Meth Mol Biol 261:383–398 

59.
Patel
RC

Kumar
U

Lamb
DC

Eid
JS

Rocheville
M

Grant
M

Rani
A

Hazlett
T

Patel
SC

Gratton
E

Patel
YC


Proc Natl Acad Sci USA
2002
99
3294
3299

11880655


60.
Maier
C

Runzler
D

Schindelar
J

Grabner
G

Waldhausl
W

Kohler
G

Luger
A


J Cell Sci
2005
118
3353
3361

16079279


61.
Bauman
JG

Wiegant
J

Borst
P

Duijn
P


Exp Cell Res
1980
128
485
490

6157553


62.
Manuelidis
L

Langer-Safer
PR

Ward
DC


J Cell Biol
1982
95
619
625

6754749


63.
Singer
RH

Ward
DC


Proc Natl Acad Sci USA
1982
79
7331
7335

6961411


64.
Santangelo
PJ

Nix
B

Tsourkas
A

Bao
G


Nucleic Acids Res
2004
32
e57

15084672


65.
Brandtzaeg
P


J Immunol Methods
1998
216
49
67

9760215


66.
Tanke
HJ

Dirks
RW

Raap
T


Curr Opin Biotech
2005
16
49
54

15722015


67.
Thomas
M

LAAszlAA
Z

Petro
K

Andrea
M

Stefan
CM


BioSystems
2006
83
188
194

16236430


68.
Cakmak
G

Togan
I

Severcan
F


Aquat Toxicol
2006
77
53
63

16325934


69.
Sonnleitner
A

Mannuzzu
LM

Terakawa
S

Isacoff
EY


Proc Natl Acad Sci USA
2002
99
12759
12764

12228726


70.
Karymov
M

Daniel
D

Sankey
OF

Lyubchenko
YL


Proc Natl Acad Sci USA
2005
102
8186
8191

15917329


71.
Li
X

Zhao
X

Fang
Y

Jiang
X

Duong
T

Fan
C

Huang
CC

Kain
SR


J Biol Chem
1998
273
34970
34975

9857028


72.
Chiang
CF

Okou
DT

Griffin
TB

Verret
CR

Williams
MN


Arch Biochem Biophys
2001
394
229
235

11594737


73.
Phelps
CB

Brand
AH


Methods
1998
14
367
379

9608508


74.
McGuire
SE

Roman
G

Davis
RL


Trends Genet
2004
20
384
391

15262411


75.
Bertrand
E

Chartrand
P

Schaefer
M

Shenoy
SM

Singer
RH

Long
RM


Mol Cell
1998
2
437
445

9809065


76.
Janicki
SM

Tsukamoto
T

Salghetti
SE

Tansey
WP

Sachidanandam
R

Prasanth
KV

Ried
T

Shav-Tal
Y

Bertrand
E

Singer
RH

Spector
DL


Cell
2004
116
683
698

15006351


77.
Stavreva
DA

Muller
WG

Hager
GL

Smith
CL

McNally
JG


Mol Cell Biol
2004
24
2682
2697

15024059


78.
Usuku
T

Nishi
M

Morimoto
M

Brewer
JA

Muglia
LJ

Sugimoto
T

Kawata
M


Neuroscience
2005
135
1119
1128

16154291


79.
Gonzalez
C

Bejarano
LA


Trends Cell Biol
2000
10
162
165

10740271


80.
Shaw
SL

Kamyar
R

Ehrhardt
DW


Science
2003
300
1715
1718

12714675


81.
Dhonukshe
P

Gadella
TW


Plant Cell
2003
15
597
611

12615935


82.
Kircher
S

Gil
P

Kozma-Bognar
L

Fejes
E

Speth
V

Husselstein-Muller
T

Bauer
D

Adam
E

Schafer
E

Nagy
F


Plant Cell
2002
14
1541
1555

12119373


83.
Mas
P

Devlin
PF

Panda
S

Kay
SA


Nature
2000
408
207
211

11089975


84.
Bunemann
M

Frank
M

Lohse
MJ


Proc Natl Acad Sci USA
2003
100
16077
16082

14673086


85.
Bhatia
S

Edidin
M

Almo
SC

Nathenson
SG


Proc Natl Acad Sci USA
2005
102
15569
15574

16221763


86.
Michnick
SW

Remy
I

Campbell-Valois
FX

Vallee-Belisle
A

Pelletier
JN


Methods Enzymol
2000
328
208
230

11075347


87.
Hu
CD

Chinenov
Y

Kerppola
TK


Mol Cell
2002
9
789
798

11983170


88.
Hu
CD

Kerppola
TK


Nat Biotechnol
2003
21
539
545

12692560


89.
Heim
R

Tsien
RY


Curr Biol
1996
6
178
182

8673464


90.
Suzuki
M

Ito
Y

Sakata
I

Sakai
T

Husimi
Y

Douglas
KT


Biochem Biophys Res Commun
2005
330
454
460

15796904


91.
Mahajan
NP

Harrison-Shostak
DC

Michaux
J

Herman
B


Chem Biol
1999
6
401
409

10375546


92.
Rehm
M

Dussmann
H

Janicke
RU

Tavare
JM

Kogel
D

Prehn
JH


J Biol Chem
2002
277
24506
24514

11964393


93.
Onuki
R

Nagasaki
A

Kawasaki
H

Baba
T

Uyeda
TQ

Taira
K


Proc Natl Acad Sci USA
2002
99
14716
14721

12409609


94.
Zhang
J

Ma
Y

Taylor
SS

Tsien
RY


Proc Natl Acad Sci USA
2001
98
14997
15002

11752448


95.
Ananthanarayanan
B

Ni
Q

Zhang
J


Proc Natl Acad Sci USA
2005
102
15081
15086

16214892


96.
Wang
Y

Botvinick
EL

Zhao
Y

Berns
MW

Usami
S

Tsien
RY

Chien
S


Nature
2005
434
1040
1045

15846350


97.
Miyawaki
A

Llopis
J

Heim
R

McCaffery
JM

Adams
JA

Ikura
M

Tsien
RY


Nature
1997
388
882
887

9278050


98.
Evanko
DS

Haydon
PG


Cell Calcium
2005
37
341
348

15755495


99.
Truong
K

Sawano
A

Mizuno
H

Hama
H

Tong
KI

Mal
TK

Miyawaki
A

Ikura
M


Nat Struct Biol
2001
8
1069
1073

11702071


100.
Palmer
AE

Jin
C

Red
JC

Tsien
RY


Proc Natl Acad Sci USA
2004
101
17404
17409

15585581


101.
Nakai
J

Ohkura
M

Imoto
K


Nat Biotechnol
2001
19
137
141

11175727


102.
Adams
SR

Harootunian
AT

Buechler
YJ

Taylor
SS

Tsien
RY


Nature
1991
349
694
697

1847505


103.
Zaccolo
M

Pozzan
T


Science
2002
295
1711
1715

11872839


104.
Dipilato
LM

Cheng
XD

Zhang
J


Proc Natl Acad Sci USA
2004
101
16513
16518

15545605


105.
Sato
M

Hida
N

Ozawa
T

Umezawa
Y


Anal Chem
2000
72
5918
5924

11140757


106.
Honda
A

Adams
SR

Sawyer
CL

Lev-Ram
V

Tsien
RY

Dostmann
WR


Proc Natl Acad Sci USA
2001
98
2437
2442

11226257


107.
Siegel
MS

Isacoff
EY


Neuron
1997
19
735
741

9354320


108.
Ataka
K

Pieribone
VA


Biophys J
2002
82
509
516

11751337


109.
Sakai
R

Repunte-Canonigo
V

Raj
CD

Knopfel
T


Eur J Neurosci
2001
13
2314
2318

11454036


110.
Miyawaki
A

Mizuno
H

Nagai
T

Sawano
A


Methods Enzymol
2003
360
202
225

12622151


111.
Hanson
GT

McAnaney
TB

Park
ES

Rendell
ME

Yarbrough
DK

Chu
S

Xi
L

Boxer
SG

Montrose
MH

Remington
SJ


Biochemistry
2002
41
15477
15488

12501176


112.
McAnaney
TB

Park
ES

Hanson
GT

Remington
SJ

Boxer
SG


Biochemistry
2002
41
15489
15494

12501177


113.
Bedner
P

Niessen
H

Odermatt
B

Kretz
M

Willecke
K

Harz
H


J Biol Chem
2006
281
6673
6681

16373337


114.
Dakin
K

Zhao
Y

Li
WH


Nat Methods
2005
2
55
62

15782161


115.
Nodin
C

Nilsson
M

Blomstrand
F


J Neurochem
2005
94
1111
1123

16092948


116.
Lyubovitsky
JG

Spencer
JA

Krasieva
TB

Andersen
B

Tromberg
BJ


J Biomed Opt
2006
11
14013

Lyubovitsky JG, Spencer JA, Krasieva TB, Andersen B, Tromberg BJ (2006) J Biomed Opt 11:14013 

117.
Filippidis
G

Kouloumentas
C

Voglis
G

Zacharopoulou
F

Papazoglou
TG

Tavernarakis
N


J Biomed Opt
2005
10
024015

15910089


118.
Dombeck
DA

Sacconi
L

Blanchard-Desce
M

Webb
WW


J Neurophysiol
2005
94
3628
3636

16093337


119.
Nuriya
M

Jiang
J

Nemet
B

Eisenthal
KB

Yuste
R


Proc Natl Acad Sci USA
2006
103
786
790

16407122


120.
Dombeck
DA

Blanchard-Desce
M

Webb
WW


J Neurosci
2004
24
999
1003

14749445


121.
Velthoven
ME

Verbraak
FD

Yannuzzi
LA

Rosen
RB

Podoleanu
AG

Smet
MD


Retina
2006
26
129
136

16467666


122.
Feldchtein
FI

Gelikonov
GV

Gelikonov
VM

Iksanov
RR

Kuranov
RV

Sergeev
AM

Gladkova
ND

Ourutina
MN

Warren
JA

Reitze
DH


Opt Express
1998
3
239
250

Feldchtein FI, Gelikonov GV, Gelikonov VM, Iksanov RR, Kuranov RV, Sergeev AM, Gladkova ND, Ourutina MN, Warren Jr JA, Reitze DH (1998) Opt Express 3:239–250 

123.
Zagaynova
EV

Streltsova
OS

Gladkova
ND

Snopova
LB

Gelikonov
GV

Feldchtein
FI

Morozov
AN


J Urol
2002
167
1492
1496

11832776


124.
Maheswari
RU

Takaoka
H

Kadono
H

Homma
R

Tanifuji
M


J Neurosci Meth
2003
124
83
92

Maheswari RU, Takaoka H, Kadono H, Homma R, Tanifuji M (2003) J Neurosci Meth 124:83–92 

125.
Whiteman
SC

Yang
Y

Pittius
DG

Stephens
M

Parmer
J

Spiteri
MA


Clin Cancer Res
2006
12
813
818

16467093


126.
Santos
LF

Wolthuis
R

Koljenovic
S

Almeida
RM

Puppels
GJ


Anal Chem
2005
77
6747
6752

16223266


127.
Koljenovic
S

Bakker Schut
TC

Meerbeeck
JP

Maat
AP

Burgers
SA

Zondervan
PE

Kros
JM

Puppels
GJ


J Biomed Opt
2004
9
1187
1197

15568939


128.
Caspers
PJ

Lucassen
GW

Puppels
GJ


Biophys J
2003
85
572
580

12829511


129.
Miyawaki
A


Curr Opin Neurobiol
2003
13
591
596

14630223


130.
Kerr
R

Lev-Ram
V

Baird
G

Vincent
P

Tsien
RY

Schafer
WR


Neuron
2000
26
583
594

10896155


131.
Shyn
SI

Kerr
R

Schafer
WR


Curr Biol
2003
13
1910
1915

14588249


132.
Fukuto
HS

Ferkey
DM

Apicella
AJ

Lans
H

Sharmeen
T

Chen
W

Lefkowitz
RJ

Jansen
G

Schafer
WR

Hart
AC


Neuron
2004
42
581
593

15157420


133.
Hilliard
MA

Apicella
AJ

Kerr
R

Suzuki
H

Bazzicalupo
P

Schafer
WR


EMBO J
2005
24
63
72

15577941


134.
Fiala
A

Spall
T

Diegelmann
S

Eisermann
B

Sachse
S

Devaud
JM

Buchner
E

Galizia
CG


Curr Biol
2002
12
1877
1884

12419190


135.
Wang
JW

Wong
AM

Flores
J

Vosshall
LB

Axel
R


Cell
2003
112
271
282

12553914


136.
Higashijima
S

Masino
MA

Mandel
G

Fetcho
JR


J Neurophysiol
2003
90
3986
3997

12930818


137.
Nyqvist
D

Mattsson
G

Kohler
M

Lev-Ram
V

Andersson
A

Carlsson
PO

Nordin
A

Berggren
PO

Jansson
L


J Endocrinol
2005
186
333
341

16079259


138.
Hara
M

Bindokas
V

Lopez
JP

Kaihara
K

Landa
LR

Harbeck
M

Roe
MW


Am J Physiol Cell Physiol
2004
287
C932
C938

15163621


139.
Metzger
F

Repunte-Canonigo
V

Matsushita
S

Akemann
W

Diez-Garcia
J

Ho
CS

Iwasato
T

Grandes
P

Itohara
S

Joho
RH

Knopfel
T


Eur J Neurosci
2002
15
40
50

11860505


140.
Stockholm
D

Bartoli
M

Sillon
G

Bourg
N

Davoust
J

Richard
I


J Mol Biol
2005
346
215
222

15663939


141.
Akerman
ME

Chan
WCW

Laakkonen
P

Bhatia
SN

Ruoslahti
E


Proc Natl Acad Sci USA
2002
99
12617
12621

12235356


142.
Stroh
M

Zimmer
JP

Duda
DG

Levchenko
TS

Cohen
KS

Brown
EB

Scadden
DT

Torchilin
VP

Bawendi
MG

Fukumura
D

Jain
RK


Nat Med
2005
11
678
682

15880117


143.
Seydel
C


Science
2003
300
80
81

12677056


144.
Lippincott-Schwartz
J

Patterson
GH


Science
2003
300
87
91

12677058


145.
Hell
SW


Nat Biotechnol
2003
21
1347
1355

14595362



Abbreviations
AFP
Aequorea
 fluorescent protein


CFP
Cyan fluorescent protein


cpGFP
Circularly permuted green fluorescent protein


cpYFP
Circularly permuted yellow fluorescent protein


EGFP
Enhanced green fluorescent protein


EYFP
Enhanced yellow fluorescent protein


FCS
Fluorescence correlation spectroscopy


FISH
Fluorescence in situ hybridization


FLIM
Fluorescence lifetime imaging microscopy


FP
Fluorescent protein


FRAP
Fluorescence recovery after photobleaching


FRET
Fluorescence resonance energy transfer


FSM
Fluorescent speckle microscopy


GFP
Green fluorescent protein


LSCM
Laser scanning confocal microscopy


MPLSM
Multiple-photon laser scanning microscopy


OMI
Optical molecular imaging


QDs
Quantum dots


RS
Raman spectroscopy


ROI
Regions of interest


SBT
Spectral bleed-through


WFM
Wide-field microscopy


YFP
Yellow fluorescent protein






